GLP-1 RAs Reduce Early-Onset Colorectal Cancer Risk in T2D

A large retrospective study, the first of its kind, reported reduced rates of EO-CRC in patients younger than 50 years of age taking the antidiabetic medications.
Medscape Medical News

source https://www.medscape.com/viewarticle/glp-1-ras-reduce-early-onset-colorectal-cancer-risk-patients-2024a1000jpu?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?